What is the appropriate plan for a 70-year-old post-menopausal female with hypertension (High Blood Pressure), hyperlipidemia (High Cholesterol), diabetes on insulin pump, and recent fractures?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Progress Note: 70-Year-Old Female with Multiple Comorbidities and Recent Fractures

Chief Complaint

Follow-up evaluation post-hospitalization for acute comminuted lumbar spine fractures and left proximal tibia-fibula fracture status-post closed reduction with intramedullary tibial nail placement.

History of Present Injury

Continue current pain management and fracture care as outlined. Patient sustained multiple fractures following slip-and-fall in shower on wet floor, requiring surgical intervention with closed reduction and intramedullary nail fixation of left distal tibia shaft fracture with proximal-distal locking screws. Currently recovering in rehabilitation facility.

Chronic Disease Management

Hypertension

Blood pressure control requires optimization given current readings and high-risk status. Current BP of [BLOOD_PRESSURE] mmHg indicates suboptimal control in this 70-year-old patient with diabetes and multiple cardiovascular risk factors 1.

  • Target BP should be <140/90 mmHg, with individualization based on frailty status 1
  • For patients <79 years, achieved systolic BP <140 mmHg is appropriate; for those >80 years, 140-145 mmHg if tolerated is acceptable 1
  • This patient qualifies as high-risk (diabetes, obesity, multiple comorbidities) and warrants immediate drug treatment optimization 1
  • Current regimen includes losartan 25 mg daily and metoprolol succinate 50 mg daily, which may require dose escalation 1
  • Consider increasing losartan to full dose (up to 100 mg daily) before adding additional agents 1
  • If BP remains uncontrolled, add thiazide-like diuretic as third-line agent 1
  • Monitor BP closely during rehabilitation stay with goal to achieve target within 3 months 1
  • Avoid excessive diastolic BP lowering below 70-75 mmHg to prevent deleterious reductions in coronary blood flow 1

Hyperlipidemia

Continue rosuvastatin 20 mg daily with current LDL-C of 80 mg/dL indicating adequate statin response. However, triglycerides of 230 mg/dL represent significant residual cardiovascular risk requiring additional intervention 2.

  • LDL-C goal of <100 mg/dL is achieved, but elevated triglycerides (230 mg/dL, goal <150 mg/dL) warrant additional therapy 2
  • After LDL-C goal is reached, consider adding omega-3 fatty acids (2-4 grams EPA+DHA daily) or fenofibrate for triglyceride reduction 2
  • Continue lifestyle modifications including reduction of saturated fat to <7% of total calories and elimination of trans-fatty acids 2
  • Recheck lipid panel in 4-12 weeks after any medication adjustment 2
  • The combination of diabetes, hypertriglyceridemia, and obesity represents metabolic syndrome with excess cardiovascular risk 3, 4

Diabetes Mellitus Type 1

Continue insulin pump therapy with current HbA1c of 7.5% indicating reasonable but suboptimal glycemic control. Improved glucose control will help address hypertriglyceridemia 5, 6.

  • Current HbA1c of 7.5% is acceptable but could be optimized to <7% if achievable without hypoglycemia risk 1
  • Continue metformin 1000 mg twice daily and insulin glargine 20 units subcutaneously daily 1
  • Improved glycemic control is effective in reducing triglyceride levels in insulin-dependent subjects 5, 6
  • Monitor blood glucose closely during rehabilitation given altered activity level and stress of recent trauma 1
  • Thiazolidinediones should be avoided given obesity (BMI 35) and multiple comorbidities 1

Obesity (BMI 35 kg/m²)

Weight reduction is critical for improving hypertension, diabetes control, and lipid profile. Target BMI 18.5-24.9 kg/m² with waist circumference <35 inches 7, 2.

  • Weight reduction and sodium restriction produce larger BP declines in older adults than in younger patients 1
  • Implement DASH eating plan (diet rich in fruits, vegetables, low-fat dairy products, low in saturated and total fat) 1
  • Engage in at least 30 minutes of moderate-intensity aerobic activity most days of the week once fractures permit 7, 2
  • Obesity is linked to insulin resistance, hyperinsulinemia, and hypertension through altered intracellular calcium metabolism and enhanced renal sodium reabsorption 8

Medication Safety Concerns

Discontinue ibuprofen immediately due to multiple contraindications. NSAIDs raise BP, increase cardiovascular risk, and should be avoided in this high-risk patient 1.

  • NSAIDs commonly raise BP levels in older adults, undermining BP control 1
  • Substitute with acetaminophen or consider alternative pain management strategies for osteoarthritis 1
  • Continue oxycodone-acetaminophen 5-325 mg as needed for fracture-related pain 1

Fracture Management

Continue current orthopedic management with close monitoring for complications. Ensure adequate calcium and vitamin D supplementation given multiple fractures and post-menopausal status.

  • Continue enoxaparin 40 mg/0.4 mL subcutaneously once daily for DVT prophylaxis during immobilization period 1
  • Monitor for signs of compartment syndrome, infection, or hardware complications 1
  • Physical therapy as tolerated to prevent deconditioning and promote fracture healing 1
  • Ensure adequate calcium (1200-1500 mg daily) and vitamin D (800-1000 IU daily) supplementation 1

Additional Comorbidities

Continue current management of COPD, obstructive sleep apnea, bipolar disorder, and secondary parkinsonism with close monitoring during rehabilitation stay.

  • Continue Advair 200-62.5-25 mcg once daily and albuterol 108 mcg as needed for COPD 1
  • Ensure CPAP compliance for obstructive sleep apnea 1
  • Continue gabapentin 300 mg daily, ondansetron 4 mg daily, and quetiapine 200 mg twice daily for bipolar disorder 1
  • Continue carbidopa-levodopa 25-100 mg and pramipexole 0.5 mg for secondary parkinsonism 1

Assessment Summary

  1. Hypertension - suboptimally controlled, requires medication adjustment 1
  2. Hyperlipidemia - LDL-C at goal but significant hypertriglyceridemia requiring additional therapy 2
  3. Diabetes mellitus type 1 - reasonable control but optimization needed 5, 6
  4. Obesity - contributing to metabolic syndrome and cardiovascular risk 3, 8
  5. Acute comminuted fractures of lumbar spine and left proximal tibia-fibula - status-post surgical repair, stable 1

Plan

  1. Increase losartan to 50 mg daily immediately, with plan to titrate to 100 mg if BP remains elevated 1
  2. Discontinue ibuprofen; substitute with acetaminophen for osteoarthritis pain 1
  3. Add omega-3 fatty acids 2-4 grams daily for hypertriglyceridemia 2
  4. Recheck lipid panel and HbA1c in 4-12 weeks 2
  5. Monitor BP daily during rehabilitation stay with goal <140/90 mmHg within 3 months 1
  6. Continue current fracture management and DVT prophylaxis 1
  7. Implement intensive lifestyle modifications including DASH diet and weight reduction program 1, 7
  8. Follow-up in clinic in 2-4 weeks post-discharge from rehabilitation 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Severe Mixed Dyslipidemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Drug treatment of combined hyperlipidemia.

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2001

Research

Lipid disorders in diabetes.

Diabetes care, 1981

Research

Pathophysiology of hyperlipidemia in diabetes mellitus.

Journal of cardiovascular pharmacology, 1990

Guideline

Management of Elevated LDL-C in Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diabetes and hypertension.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1990

Related Questions

Is a complete blood count (CBC) necessary for a patient with diabetes mellitus (DM) and hyperlipidemia at a 3-month follow-up?
How should a patient with hypercholesterolemia, hypertriglyceridemia, low HDL, elevated VLDL, elevated LDL, and hyperglycemia (Hemoglobin A1c 12.0%) be treated, who is restarting Ozempic (semaglutide) and is also on metformin and Farxiga (saxagliptin)?
How to manage a 39-year-old male with diabetes (Hemoglobin A1C 7.9%), obesity (BMI 40), hypertension, and hyperlipidemia, currently on Lisinopril?
How should I manage a 56‑year‑old obese woman with type 2 diabetes mellitus (hemoglobin A1c ≈ 8 %, fasting plasma glucose ≈ 147 mg/dL), normal hepatic and renal function, hypertriglyceridemia, low high‑density lipoprotein cholesterol, persistently elevated ferritin (~429 ng/mL) and high C‑reactive protein (~17 mg/L)?
How to approach a 55-year-old patient with diabetes (diabetes mellitus) and hypertension with acute onset dyspnea?
How to manage a finger avulsion with Surgicel (oxidized regenerated cellulose)?
What are the treatment options for patients who do not respond to traditional antidepressants, specifically atypical antidepressants like bupropion (Wellbutrin), mirtazapine (Remeron), and trazodone (Oleptro)?
What is the best treatment for a skin avulsion on a finger, including the use of Surgicel (oxidized regenerated cellulose) for hemostasis?
What is the recommended dosing regimen for Tricyclic Antidepressants (TCAs)?
What is the minimum time interval between doses of tramadol (opioid analgesic) after administering one 100mg ampoule?
What is the initial management for a patient diagnosed with Ogilvie's syndrome?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.